A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

JM Janssen; TPC Dorlo; D Niewerth; AJ Wilhelm; C.M. Zwaan; JH Beijnen; A Attarbaschi; A Baruchel; F Fagioli; T Klingebiel; B de Moerloose; G Palumbo; A Stackelberg; GJL Kaspers; ADR Huitema

doi:10.1007/s40262-019-00803-y

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

JM Janssen, TPC Dorlo, D Niewerth, AJ Wilhelm, C.M. Zwaan, JH Beijnen, A Attarbaschi, A Baruchel, F Fagioli, T Klingebiel, B de Moerloose, G Palumbo, A Stackelberg, GJL Kaspers, ADR Huitema

Pediatrics

Research output: Contribution to journal › Article › Academic › peer-review

3 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	207-216
Number of pages	10
Journal	Clinical Pharmacokinetics
Volume	59
Issue number	2
DOIs	https://doi.org/10.1007/s40262-019-00803-y
Publication status	Published - 2020

Research programs

EMC MM-02-54-03

Access to Document

10.1007/s40262-019-00803-y

Cite this

Janssen, JM., Dorlo, TPC., Niewerth, D., Wilhelm, AJ., Zwaan, C. M., Beijnen, JH., Attarbaschi, A., Baruchel, A., Fagioli, F., Klingebiel, T., de Moerloose, B., Palumbo, G., Stackelberg, A., Kaspers, GJL., & Huitema, ADR. (2020). A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Pharmacokinetics, 59(2), 207-216. https://doi.org/10.1007/s40262-019-00803-y

@article{883aed31dc67433d8e886d4a7b2de7f5,

title = "A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia",

author = "JM Janssen and TPC Dorlo and D Niewerth and AJ Wilhelm and C.M. Zwaan and JH Beijnen and A Attarbaschi and A Baruchel and F Fagioli and T Klingebiel and {de Moerloose}, B and G Palumbo and A Stackelberg and GJL Kaspers and ADR Huitema",

year = "2020",

doi = "10.1007/s40262-019-00803-y",

language = "Undefined/Unknown",

volume = "59",

pages = "207--216",

journal = "Clinical Pharmacokinetics",

issn = "0312-5963",

publisher = "Adis",

number = "2",

}

Janssen, JM, Dorlo, TPC, Niewerth, D, Wilhelm, AJ, Zwaan, CM, Beijnen, JH, Attarbaschi, A, Baruchel, A, Fagioli, F, Klingebiel, T, de Moerloose, B, Palumbo, G, Stackelberg, A, Kaspers, GJL & Huitema, ADR 2020, 'A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia', Clinical Pharmacokinetics, vol. 59, no. 2, pp. 207-216. https://doi.org/10.1007/s40262-019-00803-y

TY - JOUR

T1 - A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia

AU - Janssen, JM

AU - Dorlo, TPC

AU - Niewerth, D

AU - Wilhelm, AJ

AU - Zwaan, C.M.

AU - Beijnen, JH

AU - Attarbaschi, A

AU - Baruchel, A

AU - Fagioli, F

AU - Klingebiel, T

AU - de Moerloose, B

AU - Palumbo, G

AU - Stackelberg, A

AU - Kaspers, GJL

AU - Huitema, ADR

PY - 2020

Y1 - 2020

U2 - 10.1007/s40262-019-00803-y

DO - 10.1007/s40262-019-00803-y

M3 - Article

C2 - 31313068

SN - 0312-5963

VL - 59

SP - 207

EP - 216

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

IS - 2

ER -